Her Fight is Our Mission

Types of Fallopian Tube Cancer

Fallopian tube cancers are primarily epithelial in origin, with the majority being serous adenocarcinomas, which are aggressive and fast-growing. Less common types include:
 

• Endometrioid carcinoma: Resembles uterine cancer; generally slower growing.
   
• Clear cell carcinoma: Rare and typically more resistant to treatment.
   
• Transitional cell carcinoma: Very rare; shares features with bladder cancer.
   
• Sarcomas or mixed Müllerian tumours: Extremely rare and aggressive.

Recognising the Signs
 

Symptoms of fallopian tube cancer can be unrecognisable or mimic those of ovarian cancer. They may include:
 

• Abdominal or pelvic pain
   
• Abnormal vaginal bleeding or discharge
   
• A pelvic mass
   
• Bloating or early satiety
   
• Fatigue or unexplained weight loss
   

Many of these symptoms overlap with other gynecological conditions, making timely evaluation critical.

Understanding Risk

Risk factors for fallopian tube cancer often overlap with those for ovarian cancer:
 

• BRCA1 or BRCA2 gene mutations
   
• Lynch syndrome (a type of hereditary colorectal cancer)
   
• Personal or family history of ovarian, breast, or colorectal cancer
   
• Early attainment of menstruation or late menopause
   
• Nulliparity (never having given birth)
   

At Apollo Athenaa, women at high risk are offered genetic counselling and risk-reducing surgery.

Staging

Stage 1: Cancer affects one fallopian tube or both.
 

Stage 2: Cancer affects one fallopian tube or both and nearby tissues in the pelvis.
 

Stage 3: Cancer has spread outside the pelvis to lymph nodes or nearby organs.
 

Stage 4: Cancer has spread to the liver or distant organs like lungs or brain.
 

Our Approach to Diagnosis
 

Diagnosis of fallopian tube cancer involves a thorough evaluation, including:
 

• Pelvic ultrasound and transvaginal imaging
   
• CA-125 and other tumour marker testing
   
• MRI scan for staging and spread
   
• Histopathological analysis following biopsy or surgery
   
• Immunohistochemistry and molecular diagnostics to subtype the cancer
   

Apollo Athenaa offers high-resolution imaging and advanced pathology interpretation for timely and accurate diagnosis.

Our Approach to Treatment
 

1. Surgical Oncology
 

Surgery is the primary treatment for fallopian tube cancer and includes:
 

• Total hysterectomy with bilateral salpingo-oophorectomy (removal of both ovaries and both fallopian tubes)
   
• Pelvic lymph node dissection
   
• Cytoreductive (debulking) surgery for advanced-stage disease
   
• Fertility-preserving options may be considered in early-stage cases 
   

Surgical plans are designed by a multidisciplinary tumour board, with robotic or laparoscopic options offered for minimally invasive recovery.

2.Medical Oncology
 

Systemic therapy complements surgery and is crucial in controlling the disease:
 

• Chemotherapy is the gold standard
   
• Targeted therapy, including PARP inhibitors, may be used in patients with BRCA mutations or hormone receptive-positive tumours
   
• Precision oncology to guide personalised regimens based on tumour genetics
   
• Palliative therapy in advanced or recurrent cases to manage symptoms 
   

All treatments are delivered with compassionate monitoring in our state-of-the-art chemotherapy day care.
 

3. Radiation Oncology 

While radiation therapy is not the primary treatment for fallopian tube cancer, it may be used selectively in certain cases:
 

• Adjuvant radiation: May be considered after surgery in early-stage disease with high-risk features or residual microscopic disease.
   
• Palliative radiation: Used to relieve symptoms such as pain or bleeding in advanced-stage or recurrent disease.
   
• Stereotactic Body Radiation Therapy (SBRT) or IMRT: May be employed to target metastatic sites or residual nodal disease with precision.

Life After Cancer Diagnosis

At Apollo Athenaa, treatment is just the beginning. We offer continued support through multiple channels:

• Fertility preservation
   
• Lymphedema prevention and management
   
• Support groups and psycho-oncology services
   
• Nutrition and lifestyle counselling
   
• Menopausal health and bone health support
   
• Dermatology consultation
   
• Palliative care
   
• Regular follow-up and homecare 

Prevention and Early Detection
 

Because fallopian tube cancer is rare and often diagnosed at an advanced stage, prevention and risk-reduction strategies are critical:
 

• Genetic Testing and Counselling: For women with a strong family history or known BRCA1/2 or Lynch syndrome mutations.
   
• Risk-Reducing Salpingo-Oophorectomy: Surgical removal of the fallopian tubes and ovaries is recommended for women at high-risk, typically after childbearing is complete.
   
• Opportunistic Salpingectomy: Removal of the fallopian tubes during hysterectomy or sterilisation procedures may reduce cancer risk and is gaining acceptance as a preventive strategy even in average-risk women.
   
• Regular Surveillance: In high-risk individuals who defer surgery, close monitoring with transvaginal ultrasound and tumour markers like CA-125 may be advised, though limitations in early detection exist.
   
• Lifestyle Modifications: Maintaining a healthy weight, avoiding smoking, and regular physical activity may support overall gynecologic health.

Multidisciplinary Team-Based Care
 

Every patient with fallopian tube cancer is supported by a coordinated care team that includes:
 

• Gynecological surgical oncologists
   
• Medical oncologists
   
• Genetic counsellors
   
• Radiologists and pathologists
   
• Physiotherapists, psychologists and nutritionists
   

This integrative approach ensures every decision balances medical excellence with the patient’s individual priorities and quality of life.

At Apollo Athenaa Women’s Cancer Centre, the care for fallopian tube cancer goes beyond protocols. It is deeply personal, evidence-based, and built on the understanding that women deserve strength, dignity, and a return to the life they love.